-
Dyne Therapeutics' (DYN) Outperform Rating Reaffirmed at Royal Bank of Canada
Source: Buzz FX / 14 Jan 2025 10:46:16 America/Chicago
Dyne Therapeutics' (DYN) Outperform Rating Reaffirmed at Royal Bank of Canada Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Dyne Therapeutics ( NASDAQ:DYN - Get Free Report ) 's stock had its "outperform" rating rei
Read more...